Stock Analysis

3 German Growth Stocks With High Insider Ownership To Watch

XTRA:BKHT
Source: Shutterstock

Amidst a challenging economic landscape where the German economy is expected to contract, investors are increasingly looking towards growth stocks as potential opportunities for resilience and recovery. In this environment, companies with high insider ownership can be particularly appealing, as they often indicate strong confidence from those closest to the business.

Top 10 Growth Companies With High Insider Ownership In Germany

NameInsider OwnershipEarnings Growth
Stemmer Imaging (XTRA:S9I)25%23.2%
Exasol (XTRA:EXL)25.3%117.1%
Deutsche Beteiligungs (XTRA:DBAN)39.6%54.1%
adidas (XTRA:ADS)16.6%41.8%
pferdewetten.de (XTRA:EMH)20.6%97.9%
Alelion Energy Systems (DB:2FZ)37.4%106.6%
Beyond Frames Entertainment (DB:8WP)10.8%112.2%
R. STAHL (XTRA:RSL2)37.9%59.3%
Redcare Pharmacy (XTRA:RDC)17.4%54.3%
elumeo (XTRA:ELB)25.8%118.1%

Click here to see the full list of 21 stocks from our Fast Growing German Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Brockhaus Technologies (XTRA:BKHT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Brockhaus Technologies AG is a private equity firm with a market capitalization of €291.49 million.

Operations: The company's revenue is primarily derived from its Security Technologies segment, contributing €37.03 million, and its Financial Technologies segment, which adds €174.59 million.

Insider Ownership: 26.6%

Brockhaus Technologies is poised for substantial growth, with revenue expected to increase by 16.8% annually, outpacing the German market average. Despite a current net loss of €6.65 million for H1 2024, profitability is anticipated within three years. The company trades significantly below its estimated fair value, presenting potential investment appeal. Recent presentations at key investment conferences highlight active engagement with investors and underscore its commitment to growth and transparency in financial guidance through 2025.

XTRA:BKHT Earnings and Revenue Growth as at Oct 2024
XTRA:BKHT Earnings and Revenue Growth as at Oct 2024

Redcare Pharmacy (XTRA:RDC)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Redcare Pharmacy NV operates as an online pharmacy across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.92 billion.

Operations: The company's revenue is divided into two segments: DACH, contributing €1.74 billion, and International, generating €391 million.

Insider Ownership: 17.4%

Redcare Pharmacy is set for robust growth, with revenue projected to rise 17.5% annually, surpassing the German market average. Despite recent insider selling and past shareholder dilution, the company expects profitability within three years. Trading at a significant discount to its estimated fair value enhances its investment potential. Recent sales guidance suggests full-year 2024 revenues between €2.35 billion and €2.5 billion, reflecting improved financial prospects despite current net losses narrowing from last year.

XTRA:RDC Earnings and Revenue Growth as at Oct 2024
XTRA:RDC Earnings and Revenue Growth as at Oct 2024

Zalando (XTRA:ZAL)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Zalando SE operates an online platform for fashion and lifestyle products, with a market cap of €7.76 billion.

Operations: The company generates revenue from its online platform for fashion and lifestyle products, amounting to €10.49 billion.

Insider Ownership: 10.4%

Zalando's earnings are projected to grow significantly at 24.4% annually, outpacing the German market. Despite a modest revenue growth forecast of 5.6%, recent financial performance shows strong profit growth with net income rising to €95.7 million in Q2 2024 from €56.6 million a year ago. The stock trades well below its estimated fair value, offering potential upside, although insider ownership details are limited and CFO changes may introduce uncertainty.

XTRA:ZAL Earnings and Revenue Growth as at Oct 2024
XTRA:ZAL Earnings and Revenue Growth as at Oct 2024

Summing It All Up

Looking For Alternative Opportunities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if Brockhaus Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com